12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Avastin bevacizumab regulatory update

Roche disclosed in its 4Q10 earnings that in December it submitted an application to the European Medicines Agency (EMA) for Avastin bevacizumab to treat metastatic ovarian cancer. Roche expects to submit a regulatory...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >